FTC seeks more information on Boston Scientific's $3.7 bln Axonics deal (updated)

Axonics

04/04/2024 12:45

(Adds details from regulatory filing in paragraphs 2-4)
       April 4 (Reuters) - Boston Scientific  BSX.N  said on
Thursday the U.S. Federal Trade Commission (FTC) has requested
additional information from the medical device maker related to
its $3.7 billion deal to buy Axonics  AXNX.O .
    In a regulatory filing, Boston Scientific said Axonics has
also received a request for additional information from the FTC
and both the companies expect to respond promptly. 
    Boston said it now expects the deal, announced in January,
to be completed in the second half of 2024 following the FTC's
request, compared to its previous estimate of first half.


 (Reporting by Bhanvi Satija in Bengaluru; Editing by Shilpi
Majumdar and Shinjini Ganguli)
 ((Bhanvi.Satija@thomsonreuters.com; Outside U.S. +91
9873062788;))